华纳药厂：硫酸沙丁胺醇注射液获药品注册证书

Core Viewpoint - Warner Pharmaceuticals has received approval from the National Medical Products Administration for the registration certificate of Salbutamol Sulfate Injection, which is intended for the treatment of bronchial asthma and wheezing bronchitis associated with bronchospasm [1] Group 1 - The drug is classified as a Category 3 chemical drug under the new registration classification, indicating it has passed the consistency evaluation [1] - The acquisition of this registration certificate enriches the company's formulation product variety, positively impacting the optimization of the company's product structure [1]